Pfizer (France)

774 papers and 20.2k indexed citations i.

About

In recent decades, authors affiliated with Pfizer (France) have published 774 papers, which have received a total of 20.2k indexed citations. Scholars at this organization have produced 180 papers in Epidemiology, 116 papers in Molecular Biology and 97 papers in Infectious Diseases on the topics of Pneumonia and Respiratory Infections (95 papers), Respiratory viral infections research (53 papers) and Chronic Lymphocytic Leukemia Research (52 papers). Their work is cited by papers focused on Molecular Biology (4.0k citations), Epidemiology (3.8k citations) and Rheumatology (2.3k citations). Authors at Pfizer (France) collaborate with scholars in France, United States and United Kingdom and have published in prestigious journals including Nature, Circulation and Journal of Clinical Oncology. Some of Pfizer (France)'s most productive authors include Jean‐Philippe Raynaud, Leopold Goetze, J. Cronin, I. Martin Sheldon, Claude Bertrand, Gaetano Donofrío, Hans‐Joachim Schuberth, G. Hanton, Vincent Lagente and Claudie Charbonneau.

In The Last Decade

Fields of papers published by authors at Pfizer (France)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Pfizer (France) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Pfizer (France) at the time of their publication.

Countries citing scholars working at Pfizer (France)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Pfizer (France). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Pfizer (France) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pfizer (France) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025